Literature DB >> 20576226

IL-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan.

Ying-Ju Lin1, Lei Wan, C-M Huang, J J-C Sheu, S-Y Chen, T-H Lin, D-Y Chen, K-C Hsueh, C-C Lai, F-J Tsai.   

Abstract

OBJECTIVES: The genetic control of Interleukin-10 (IL-10) and Tumour necrosis factor-alpha (TNF-alpha) production and the possible interaction between the two cytokines in influencing SLE susceptibility as well as clinical features has not been completely evaluated in the Taiwanese population.
METHODS: We investigated the association of IL-10 and TNF-alpha promoter polymorphisms (-1082, -819 and -592 for IL-10 gene; -308 for TNF-alpha gene) with SLE in a total of 172 Taiwanese patients and 215 controls.
RESULTS: Our results indicate that IL-10 A/T/A-A/T/A genotype was associated with Taiwanese SLE, whereas no significance was observed between TNF-alpha genotype and SLE. Furthermore, the TNF-alpha G allele frequency of the polymorphism at -308 was significantly decreased in patients with oral ulcers. The combined frequencies of IL-10 A/T/A haplotype and TNF-alpha G-G genotype were significantly increased in SLE patients. In addition, the combined frequencies of IL-10 A/T/A haplotype and TNF-alpha G-G genotype were significantly decreased in patients with oral ulcers.
CONCLUSIONS: These results suggest a significant correlation of the combined IL-10 and TNF-alpha genetic polymorphisms contribute to SLE susceptibility and clinical features in the Taiwanese population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20576226

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

Review 1.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

2.  Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.

Authors:  Sander I van Leuven; Yanice V Mendez-Fernandez; Ashley J Wilhelm; Nekeithia S Wade; Curtis L Gabriel; John J Kastelein; Erik S Stroes; Paul P Tak; Amy S Major
Journal:  Ann Rheum Dis       Date:  2011-09-27       Impact factor: 19.103

3.  Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus.

Authors:  Arezou Rezaei; Vahid Ziaee; Fatemeh Tahghighi Sharabian; Sara Harsini; Maryam Mahmoudi; Samaneh Soltani; Maryam Sadr; Mohammad Hassan Moradinejad; Yahya Aghighi; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2015-01-30       Impact factor: 2.980

Review 4.  Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.

Authors:  Hui Peng; Wei Wang; Mo Zhou; Rui Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2013-05-25       Impact factor: 2.980

5.  Lack of association between the haplotype GCC/ATA polymorphism in the IL-10 promoter and SLE risk: evidence from a meta-analysis.

Authors:  B Wang; Y-G Fan; D-Q Ye
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

6.  Synergetic Interaction of HLA-DRB1*07 Allele and TNF-Alpha - 863 C/A Single Nucleotide Polymorphism in the Susceptibility to Systemic Lupus Erythematosus.

Authors:  Shiva Krishna Katkam; Liza Rajasekhar; Fathima S D Tasneem; Vijay Kumar Kutala
Journal:  Indian J Clin Biochem       Date:  2019-10-18

Review 7.  Genetic risk factors of systemic lupus erythematosus in the Malaysian population: a minireview.

Authors:  Hwa Chia Chai; Maude Elvira Phipps; Kek Heng Chua
Journal:  Clin Dev Immunol       Date:  2011-09-20

8.  IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.

Authors:  Ping Liu; Jianwen Song; Hui Su; Linli Li; Ning Lu; Rongli Yang; Zhenhui Peng
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.